Literature DB >> 10499116

Conductive hearing loss in individuals with fibrodysplasia ossificans progressiva.

C E Levy1, A T Lash, H B Janoff, F S Kaplan.   

Abstract

Fibrodysplasia ossificans progressiva (FOP) is a very rare genetic disorder that is characterized by progressive heterotopic ossification of soft tissues and congenital malformation of the great toes. Although previous case studies have reported hearing loss in individuals with FOP, there have been no large-scale studies regarding the nature or cause of the hearing loss. Here, we report the findings of a two-part study. In Part I, we report the findings of a postal survey regarding hearing loss that was sent to 102 individuals with FOP. In Part II, we report the findings of on-site hearing evaluations of eight individuals with FOP. The findings of both studies indicate that individuals with FOP are at risk for hearing loss and that the type of loss is predominantly conductive in nature, similar to that seen in individuals who have otosclerosis.

Entities:  

Mesh:

Year:  1999        PMID: 10499116     DOI: 10.1044/1059-0889(1999/011)

Source DB:  PubMed          Journal:  Am J Audiol        ISSN: 1059-0889            Impact factor:   1.493


  17 in total

Review 1.  Fibrodysplasia ossificans progressiva: clinical course, genetic mutations and genotype-phenotype correlation.

Authors:  Irina Hüning; Gabriele Gillessen-Kaesbach
Journal:  Mol Syndromol       Date:  2014-08-07

Review 2.  Fibrodysplasia ossificans progressiva: a current review of imaging findings.

Authors:  Adam H Bauer; Jeff Bonham; Luis Gutierrez; Edward C Hsiao; Daria Motamedi
Journal:  Skeletal Radiol       Date:  2018-02-14       Impact factor: 2.199

Review 3.  Fibrodysplasia ossificans progressiva: diagnosis, management, and therapeutic horizons.

Authors:  Robert J Pignolo; Eileen M Shore; Frederick S Kaplan
Journal:  Pediatr Endocrinol Rev       Date:  2013-06

4.  Neurological symptoms in individuals with fibrodysplasia ossificans progressiva.

Authors:  Joseph A Kitterman; Jonathan B Strober; Lixin Kan; David M Rocke; Amanda Cali; Jeannie Peeper; Jennifer Snow; Patricia L R Delai; Rolf Morhart; Robert J Pignolo; Eileen M Shore; Frederick S Kaplan
Journal:  J Neurol       Date:  2012-06-30       Impact factor: 4.849

Review 5.  Granting immunity to FOP and catching heterotopic ossification in the Act.

Authors:  Frederick S Kaplan; Robert J Pignolo; Eileen M Shore
Journal:  Semin Cell Dev Biol       Date:  2015-12-17       Impact factor: 7.727

6.  Rarely occurring mutation of ACVR1 gene in Moroccan patient with fibrodysplasia ossificans progressiva.

Authors:  Ilham Ratbi; Renata Bocciardi; Asmaa Regragui; Roberto Ravazzolo; Abdelaziz Sefiani
Journal:  Clin Rheumatol       Date:  2009-10-01       Impact factor: 2.980

Review 7.  Fibrodysplasia ossificans progressiva.

Authors:  Frederick S Kaplan; Martine Le Merrer; David L Glaser; Robert J Pignolo; Robert E Goldsby; Joseph A Kitterman; Jay Groppe; Eileen M Shore
Journal:  Best Pract Res Clin Rheumatol       Date:  2008-03       Impact factor: 4.098

Review 8.  Cardiopulmonary and Neurologic Dysfunctions in Fibrodysplasia Ossificans Progressiva.

Authors:  Fatima Khan; Xiaobing Yu; Edward C Hsiao
Journal:  Biomedicines       Date:  2021-02-05

9.  From mysteries to medicines: drug development for fibrodysplasia ossificans progressive.

Authors:  Frederick S Kaplan; Robert J Pignolo; Eileen M Shore
Journal:  Expert Opin Orphan Drugs       Date:  2013-08       Impact factor: 0.694

Review 10.  Fibrodysplasia ossificans progressiva: mechanisms and models of skeletal metamorphosis.

Authors:  Frederick S Kaplan; Salin A Chakkalakal; Eileen M Shore
Journal:  Dis Model Mech       Date:  2012-11       Impact factor: 5.758

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.